Chemical formula: C₁₃₆H₂₁₀N₄₀O₃₁S Molecular mass: 2,933.49 g/mol PubChem compound: 16133751
There is a limited amount of data on the use of tetracosactide in pregnant patients. Data from animal studies are insufficient with respect to reproductive toxicity. Tetracosactide should be used during pregnancy only if the expected benefit outweighs the potential risk to the foetus.
It is unknown whether tetracosactide is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when tetracosactide is administered to a breastfeeding woman.
No special recommendation.
There is no data available.
Patients should be warned of the potential hazards of driving or operating machinery if they experience side effects such as dizziness.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
